Monitor for actual sales via subsequent Form 4 filings. The cluster of intent-to-sell filings from a director and two Atlas Venture funds suggests potential near-term overhang. Given the small relative size, the direct price impact is likely limited, but the signal may weigh on sentiment. Watch for any upcoming catalyst (e.g., data readouts) that could accelerate or delay execution of these sales.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 18 $90.43entry
- T+1 · 5mo ago +9.97%α +10.29% · $99.45
- T+5 · 5mo ago +28.78%α +30.45% · $116.46
- T+20 · 4mo ago +26.05%α +25.52% · $113.99
- T+60 · 2mo ago +26.76%α +24.87% · $114.63
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Form 144 filings from Kymera Therapeutics on June 17, 2026, signal intent to sell by director Bruce Booth (11,741 shares, ~$1.03M) and two Atlas Venture entities (Atlas Venture Fund X: 92,169 shares, ~$8.06M; Atlas Venture Opportunity Fund I: 12,902 shares, ~$1.13M). Combined proposed sales total ~116,812 shares worth ~$10.2M, representing ~0.14% of shares outstanding. While the dollar amount is modest relative to the $7.2B market cap, the coordinated filing by a director and major venture backers on the same day is a mildly negative signal.
Key Facts
- Bruce Booth (Director) filed to sell 11,741 shares valued at ~$1,026,633.
- Atlas Venture Fund X, L.P. filed to sell 92,169 shares valued at ~$8,059,257.
- Atlas Venture Opportunity Fund I, L.P. filed to sell 12,902 shares valued at ~$1,128,151.
- Total proposed sales: 116,812 shares worth ~$10,214,041.
- All three filings were made on June 17, 2026, indicating coordinated insider/affiliate selling intent.
- Shares to be sold were acquired via stock options (Booth) and private placements (Atlas) in 2020.
Financial Impact
Proposed sales of ~$10.2M, representing ~0.14% of market cap ($7.2B).
Risk Factors
- Insider selling may signal lack of confidence in near-term prospects.
- Potential overhang if all shares are sold within the 90-day window.
- Further selling by other insiders or affiliates could follow.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (KYMR), Batch item 1 | 0001628280-26-044009 |
| Document: 0001628280-26-044009-index.html | 0001628280-26-044011 |
| Document: 0001628280-26-044009.txt | 0001628280-26-044012 |
| 144 Filing (KYMR), Batch item 4 | 0001628280-26-044011 |
| Document: 0001628280-26-044011-index.html | 0001628280-26-044009 |
| Document: 0001628280-26-044011.txt | 0001628280-26-044009 |
| 144 Filing (KYMR), Batch item 7 | 0001628280-26-044012 |
| Document: 0001628280-26-044012-index.html | 0001628280-26-044009 |
| Document: 0001628280-26-044012.txt | 0001628280-26-044009 |
Track record
37 reports on KYMR
7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 13 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers